GlaxoSmithKline (LSE: GSK) is often pegged as a super-safe income stock due to the rock solid demand for drugs — and its 5.8% dividend yield — but the fact is this business is in transition and at the moment its payout looks perilously uncovered. However, there’s a reason to be optimistic… sort of.
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.
Is GlaxoSmithKline plc’s Dividend Safe?
VIDEO: One Fool puts GlaxoSmithKline plc (LON:GSK) under the spotlight.
You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.